Fortress Biotech, Inc. Diluted Shares Outstanding (Weighted Average)
Fortress Biotech, Inc. (FBIO) reported Diluted Shares Outstanding (Weighted Average) of 31.79 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-13
- Fortress Biotech, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 31.79M shares, a 6.60% increase year-over-year.
- Fortress Biotech, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 38.41M shares, a 45.23% increase year-over-year.
- Fortress Biotech, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 19.52M shares, a 24.96% decline year-over-year.
- Fortress Biotech, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 33.10M shares, a 68.05% increase year-over-year.
- Fortress Biotech, Inc. weighted average number of shares outstanding, diluted for fiscal 2025 was 27.90M shares, a 34.24% increase from fiscal 2024.
- Fortress Biotech, Inc. weighted average number of shares outstanding, diluted for fiscal 2024 was 20.78M shares, a 156.25% increase from fiscal 2023.
- Fortress Biotech, Inc. weighted average number of shares outstanding, diluted for fiscal 2023 was 8.11M shares, a 36.89% increase from fiscal 2022.
- Fortress Biotech, Inc. weighted average number of shares outstanding, diluted for fiscal 2022 was 5.92M shares, a 92.75% decline from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 31.79M shares 10-Q · filed 2026-08-13 | 37.01M shares 10-Q · filed 2026-08-13 | 29.91M shares derived: average of 3 quarters · filed 2026-08-13 | 30.71M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | 38.41M shares 10-Q · filed 2026-05-14 | 28.97M shares derived: average of 2 quarters · filed 2026-05-14 | 30.34M shares derived: average of 3 quarters · filed 2026-05-14 | 30.21M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | 19.52M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 26.31M shares derived: average of 2 quarters · filed 2026-03-31 | 27.48M shares derived: average of 3 quarters · filed 2026-08-13 | 27.90M shares 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | 33.10M shares 10-Q · filed 2025-11-14 | 31.46M shares derived: average of 2 quarters · filed 2026-08-13 | 30.70M shares 10-Q · filed 2025-11-14 | 28.85M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | 29.82M shares 10-Q · filed 2026-08-13 | 29.18M shares 10-Q · filed 2026-08-13 | 27.43M shares derived: average of 3 quarters · filed 2026-08-13 | 25.50M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | 26.45M shares 10-Q · filed 2026-05-14 | 26.23M shares derived: average of 2 quarters · filed 2026-05-14 | 24.05M shares derived: average of 3 quarters · filed 2026-05-14 | 22.62M shares derived: average of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | 26.01M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 22.85M shares derived: average of 2 quarters · filed 2026-03-31 | 21.34M shares derived: average of 3 quarters · filed 2026-03-31 | 20.78M shares 10-K · filed 2026-03-31 | ||||
| 2024-09-30 | 19.70M shares 10-Q · filed 2025-11-14 | 19.01M shares derived: average of 2 quarters · filed 2025-11-14 | 19.04M shares 10-Q · filed 2025-11-14 | 16.48M shares derived: average of 4 quarters · filed 2025-11-14 | ||||
| 2024-06-30 | 18.32M shares 10-Q · filed 2025-08-14 | 17.74M shares 10-Q · filed 2025-08-14 | 15.41M shares derived: average of 3 quarters · filed 2025-08-14 | 13.43M shares derived: average of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | 17.15M shares 10-Q · filed 2025-05-15 | 13.95M shares derived: average of 2 quarters · filed 2025-05-15 | 11.80M shares derived: average of 3 quarters · filed 2025-05-15 | 10.69M shares derived: average of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | 10.75M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 9.12M shares derived: average of 2 quarters · filed 2025-03-31 | 8.54M shares derived: average of 3 quarters · filed 2025-03-31 | 8.11M shares 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | 7.50M shares 10-Q · filed 2024-11-14 | 7.44M shares derived: average of 2 quarters · filed 2024-11-14 | 7.23M shares 10-Q · filed 2024-11-14 | 30.70M shares derived: average of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | 7.38M shares 10-Q · filed 2024-08-13 | 110.66M shares 10-Q · filed 2023-08-14 | 7.09M shares 10-Q · filed 2024-08-13 | 106.30M shares 10-Q · filed 2023-08-14 | 38.43M shares derived: average of 3 quarters · filed 2024-08-13 | 30.32M shares derived: average of 4 quarters · filed 2024-08-13 | ||
| 2023-03-31 | 101.89M shares 10-Q · filed 2023-05-15 | 53.96M shares derived: average of 2 quarters · filed 2024-03-28 | 37.96M shares derived: average of 3 quarters · filed 2024-03-28 | 50.66M shares derived: average of 4 quarters · filed 2024-03-28 | ||||
| 2022-12-31 | 6.04M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | 6.00M shares derived: average of 2 quarters · filed 2024-03-28 | 33.58M shares derived: average of 3 quarters · filed 2024-03-28 | 5.92M shares 10-K · filed 2024-03-28 | 88.87M shares 10-K · filed 2023-03-31 | |||
| 2022-09-30 | 5.96M shares 10-Q · filed 2023-11-14 | 89.42M shares 10-Q · filed 2022-11-14 | 47.35M shares derived: average of 2 quarters · filed 2023-11-14 | 5.89M shares 10-Q · filed 2023-11-14 | 88.29M shares 10-Q · filed 2022-11-14 | 66.15M shares derived: average of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | 88.74M shares 10-Q · filed 2023-08-14 | 87.59M shares 10-Q · filed 2023-08-14 | 86.21M shares derived: average of 3 quarters · filed 2023-08-14 | 84.99M shares derived: average of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | 86.26M shares 10-Q · filed 2023-05-15 | 84.94M shares derived: average of 2 quarters · filed 2023-05-15 | 83.75M shares derived: average of 3 quarters · filed 2023-05-15 | 83.05M shares derived: average of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | 83.63M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | 82.49M shares derived: average of 2 quarters · filed 2023-03-31 | 81.98M shares derived: average of 3 quarters · filed 2023-03-31 | 81.70M shares 10-K · filed 2023-03-31 | ||||
| 2021-09-30 | 81.35M shares 10-Q · filed 2022-11-14 | 81.16M shares derived: average of 2 quarters · filed 2022-11-14 | 81.06M shares 10-Q · filed 2022-11-14 | |||||
| 2021-06-30 | 80.96M shares 10-Q · filed 2022-08-11 | 80.91M shares 10-Q · filed 2022-08-11 | ||||||
| 2021-03-31 | 80.85M shares 10-Q · filed 2022-05-12 | |||||||
| 2020-03-31 | 63.50M shares 10-Q · filed 2020-05-11 | |||||||
| 2019-03-31 | 63.81M shares 10-Q · filed 2020-05-11 | |||||||
| 2018-03-31 | 42.52M shares 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |